Akebia Therapeutics reported $24.47M in Trade Debtors for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 46M 2M
Acceleron Pharma XLRN:US $ 39M 31M
Akebia Therapeutics AKBA:US $ 24.47M 14.65M
Alexion Pharmaceuticals ALXN:US $ 1372.2M 27M
Alnylam Pharmaceuticals ALNY:US $ 579.12M 510M
Amgen AMGN:US $ 5366M 357M
AstraZeneca AZN:LN 6B 763M
Bayer BAYN:GR 1.57B 95.3M
Biomarin Pharmaceutical BMRN:US $ 381.22M 15.17M
Exelixis EXEL:US $ 134M 3M
Fresenius Medical Care FME:GR € 3581.38M 254.68M
GlaxoSmithKline GSK:LN 749.6M 139.9M
Intercept Pharmaceuticals ICPT:US $ 39.78M 4.08M
Ironwood Pharmaceuticals IRWD:US $ 113.25M 7.87M
Johnson & Johnson JNJ:US $ 14579M 66M
Opko Health OPK:US $ 256.33M 29.18M
Prothena PRTA:US 22K 34K
Ptc Therapeutics PTCT:US $ 53.64M 1.02M
Regeneron Pharmaceuticals REGN:US $ 2811.3M 121.9M
Sarepta Therapeutics SRPT:US $ 107M 2M
Seattle Genetics SGEN:US $ 293.42M 3.34M
Vanda Pharmaceuticals VNDA:US $ 24.59M 4.68M